Nestlé S.A. (NSRGF)
| Previous Close | 117.15 |
| Open | 117.87 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 117.87 - 119.49 |
| 52 Week Range | 102.00 - 134.00 |
| Volume | |
| Avg. Volume | 7,116 |
| Market Cap | 316.099B |
| Beta (5Y Monthly) | 0.30 |
| PE Ratio (TTM) | 32.21 |
| EPS (TTM) | 3.67 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 3.19 (2.72%) |
| Ex-Dividend Date | Apr 24, 2023 |
| 1y Target Est | 137.69 |
- GlobeNewswire
Nestlé publishes its 2022 Annual Report and its Creating Shared Value and Sustainability Report
[Ad hoc announcement pursuant to Art. 53 LR] Vevey, March 21, 2023 This press release is also available in Français (pdf) and Deutsch (pdf) ............. Nestlé publishes its 2022 Annual Report and its Creating Shared Value and Sustainability Report Today, Nestlé is publishing its 2022 Annual Report alongside its Creating Shared Value and Sustainability (CSV) Report. As the publications highlight, Nestlé’s results were resilient in a year defined by many challenges. Staying on course required a
- Thomson Reuters StreetEvents
Q4 2022 Seres Therapeutics Inc Earnings Call
Q4 2022 Seres Therapeutics Inc Earnings Call
- Bloomberg
Nestlé Is Said to Kick Off Sale of Peanut Allergy Pill Palforzia
(Bloomberg) -- Nestlé SA has kicked off the sale of its peanut allergy medicine, people with knowledge of the matter said, as it seeks to reverse what’s proven to be a costly bet for the consumer company.Most Read from BloombergSorry, Twitter. Elon Found His Next Shiny Object.How to Get a Free Flight to Hong Kong in 500,000 Airline Ticket GiveawayWorld’s Rich Take Advantage as $1 Trillion Property Market CratersLightfoot Is First Chicago Mayor to Lose Reelection in 40 YearsMusk Was Right About T
